NASDAQ:VICL

Vical (VICL) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.68
$3.15
52-Week Range
N/A
Volume
35,024 shs
Average Volume
1.44 million shs
Market Capitalization
$21.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VICL stock logo

About Vical Stock (NASDAQ:VICL)

Vical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The company was founded in 1987 and is headquartered in San Diego, California.

VICL Stock News Headlines

A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
This song is our story
See More Headlines
Receive VICL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/19/2019
Today
4/24/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:VICL
CUSIP
92560210
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Net Income
$-16,250,000.00
Net Margins
-1,002.10%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.62 million
Book Value
$1.82 per share

Miscellaneous

Free Float
N/A
Market Cap
$21.01 million
Optionable
Not Optionable
Beta
0.32
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Vijay B. Samant (Age 66)
    CEO, Pres & Director
  • Dr. Lawrence Russell Smith (Age 58)
    Sr. VP of Research
  • Mr. Anthony Alan Ramos (Age 52)
    VP, CFO & Chief Accounting Officer
  • Dr. Mammen P. Mammen Jr. (Age 55)
    Former Sr. VP of Clinical Devel.

VICL Stock Analysis - Frequently Asked Questions

How were Vical's earnings last quarter?

Vical Incorporated (NASDAQ:VICL) released its earnings results on Tuesday, February, 19th. The biotechnology company reported ($0.17) earnings per share for the quarter, hitting the consensus estimate of ($0.17). The biotechnology company earned $0.12 million during the quarter, compared to the consensus estimate of $0.04 million. Vical had a negative net margin of 1,002.10% and a negative trailing twelve-month return on equity of 29.46%.

What other stocks do shareholders of Vical own?
This page (NASDAQ:VICL) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners